InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Swirsky Douglas J, 董事. Officer active across 2 companies, notably Cellectar Biosciences, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €104k. Activity tracked since 14 September 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Douglas J. Swirsky is a Board Member at Cellectar Biosciences, Inc. He plays an important role in overseeing the company's activities and developing its growth strategy.